| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2725027 | The American Journal of Medicine | 2007 | 8 Pages |
Abstract
Our retrospective study is the first to determine the annual incidence of malignant lymphoma among patients with HCV at 0.23%. Our results indicate that sustained virologic response induced by interferon therapy protects against the development of malignant lymphoma in patients with chronic HCV.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yusuke MD, Kenji MD, Yasuji MD, Hiromi MD, Hitomi MD, Tetsuya MD, Norio MD, Masahiro MD, Fumitaka MD, Yoshiyuki MD, Hiromitsu MD,